Bio-Techne (TECH) Interest Expenses (2014 - 2026)
Bio-Techne's quarterly Interest Expenses came in at $2.4 million in Q1 2026, up 19.68% year-on-year from $2.0 million in Q1 2025, and up 10.64% quarter-over-quarter from $2.2 million in Q4 2025.
Bio-Techne has reported Interest Expenses for 13 years, with the latest figure at $2.4 million in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses rose 19.68% year-over-year to $2.4 million; the trailing twelve-month figure through Mar 2026 stood at $9.7 million (up 9.56% YoY), and the FY2025 full-year result was $8.5 million, down 45.93% from the prior year.
- Interest Expenses for Q1 2026 stood at $2.4 million, up from $2.2 million in the prior quarter.
- The five-year high for Interest Expenses was $4.9 million in Q3 2023, with the low at $1.4 million in Q1 2023.
- Average Interest Expenses over 5 years is $2.8 million, with a median of $2.5 million recorded in 2022.
- Peak annual rise in Interest Expenses reached 192.98% in 2024, while the deepest fall reached 55.53% in 2024.
- Tracing TECH's Interest Expenses over 5 years: stood at $2.4 million in 2022, then jumped by 83.74% to $4.3 million in 2023, then plunged by 50.38% to $2.1 million in 2024, then rose by 1.07% to $2.2 million in 2025, then gained by 10.64% to $2.4 million in 2026.
- The last three Interest Expenses figures came in at $2.4 million (Q1 2026), $2.2 million (Q4 2025), and $2.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 2.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.40 Mn |
| Mar 31, 2026 | 2.40 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Dec 31, 2025 | 2.17 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Sep 30, 2025 | 2.93 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Jun 30, 2025 | 2.18 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.01 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Sep 30, 2024 | 2.18 Mn |
| Jun 30, 2024 | 2.51 Mn |
| Jun 30, 2024 | 2.51 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Dec 31, 2023 | 4.33 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Sep 30, 2023 | 4.89 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Jun 30, 2023 | 3.70 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 2.36 Mn |
| Dec 31, 2022 | 2.36 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Sep 30, 2022 | 3.79 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Jun 30, 2022 | 2.51 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Mar 31, 2022 | 2.49 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Dec 31, 2021 | 2.90 Mn |
| Sep 30, 2021 | 3.41 Mn |
| Sep 30, 2021 | 3.41 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Jun 30, 2021 | 3.29 Mn |
| Mar 31, 2021 | 2.66 Mn |
| Mar 31, 2021 | 2.66 Mn |
| Dec 31, 2020 | 3.59 Mn |
| Dec 31, 2020 | 3.59 Mn |
| Sep 30, 2020 | 4.42 Mn |
| Sep 30, 2020 | 4.42 Mn |
| Jun 30, 2020 | 4.62 Mn |
| Jun 30, 2020 | 4.62 Mn |
| Mar 31, 2020 | 4.49 Mn |
| Mar 31, 2020 | 4.49 Mn |
| Dec 31, 2019 | 4.87 Mn |
| Dec 31, 2019 | 4.87 Mn |
| Sep 30, 2019 | 5.22 Mn |
| Sep 30, 2019 | 5.22 Mn |
| Jun 30, 2019 | 5.60 Mn |
| Jun 30, 2019 | 5.60 Mn |
| Mar 31, 2019 | 5.11 Mn |
| Mar 31, 2019 | 5.11 Mn |
| Dec 31, 2018 | 5.76 Mn |
| Dec 31, 2018 | 5.76 Mn |
| Sep 30, 2018 | 5.24 Mn |
| Sep 30, 2018 | 5.24 Mn |
| Jun 30, 2018 | -4.95 Mn |
| Jun 30, 2018 | -4.95 Mn |
| Mar 31, 2018 | 2.56 Mn |
| Mar 31, 2018 | 2.56 Mn |
| Dec 31, 2017 | 2.33 Mn |
| Dec 31, 2017 | 2.33 Mn |
| Sep 30, 2017 | 2.24 Mn |
| Sep 30, 2017 | 2.24 Mn |
| Jun 30, 2017 | 2.16 Mn |
| Jun 30, 2017 | 2.16 Mn |
| Mar 31, 2017 | 86,000.00 |
| Mar 31, 2017 | 86,000.00 |
| Dec 31, 2016 | 86,000.00 |
| Dec 31, 2016 | 86,000.00 |
| Sep 30, 2016 | 57,000.00 |
| Sep 30, 2016 | 57,000.00 |
| Jun 30, 2016 | 433,000.00 |
| Jun 30, 2016 | 433,000.00 |
| Mar 31, 2016 | 448,000.00 |
| Mar 31, 2016 | 448,000.00 |
| Dec 31, 2015 | 400,000.00 |
| Dec 31, 2015 | 400,000.00 |
| Sep 30, 2015 | 451,000.00 |
| Sep 30, 2015 | 451,000.00 |
| Jun 30, 2015 | 388,000.00 |
| Jun 30, 2015 | 388,000.00 |
| Mar 31, 2015 | 414,000.00 |
| Mar 31, 2015 | 414,000.00 |
| Dec 31, 2014 | 437,000.00 |
| Dec 31, 2014 | 437,000.00 |
| Sep 30, 2014 | 311,000.00 |
| Sep 30, 2014 | 311,000.00 |